Efficacy of high doses of intravenous fosfomycin for treatment of urinary tract infection caused by KPC carbapenemase-producing Klebsiella pneumoniae: An observational study
ABSTRACT: Objective: To evaluate the efficacy of high-dose intravenous fosfomycin for the treatment of urinary tract infections (UTI) caused by KPC carbapenemase-producing Klebsiella pneumoniae (KPC-Kp). A secondary objective was to evaluate the impact of the results of fosfomycin susceptibility te...
Saved in:
| Main Authors: | Jorge Rodríguez-Gómez, Irene Gracia-Ahufinger I, Rosario Carmona-Flores, Julia Guzmán-Puche, Rafael León, Elena Pérez-Nadales, Monserrat Muñoz de la Rosa, Alejandra Mendez Natera, Juan José Castón, Ángela Cano, Juan Jesús Pineda-Capitán, Cristina López, Carmen De la Fuente-Martos, Julián Torre-Cisneros, Luis Martínez-Martínez |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2025-03-01
|
| Series: | Journal of Global Antimicrobial Resistance |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2213716524004764 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Tigecycline and intravenous fosfomycin zone breakpoints equivalent to the EUCAST MIC criteria for Enterobacteriaceae
by: Fernando Pasteran, et al.
Published: (2012-02-01) -
In vitro susceptibility of OXA-48, NDM, VIM and IMP enzyme- producing Klebsiella spp. and Escherichia coli to fosfomycin
by: Selay Demirci-Duarte, et al.
Published: (2020-04-01) -
Detection of the novel IMP-38 among carbapenemase-producing Enterobacteriaceae in a university hospital, China
by: Zijuan Jian, et al.
Published: (2014-08-01) -
Detection of carbapenemase-producing bacteria in a public healthcare center from Venezuela
by: Liliana Gomez-Gamboa, et al.
Published: (2020-12-01) -
Antimicrobial resistance and phylogenetic lineages of KPC-2-producing blood-borne Klebsiella pneumoniae subsp. pneumoniae from Kolkata, India during 2015–2024: Emergence of Klebsiella pneumoniae subsp. pneumoniae with blaKPC-2, blaNDM, and blaOXA-48-like triple carbapenemases
by: Gourab Halder, et al.
Published: (2025-08-01)